Imaging Biomarkers in Duchenne Muscular Dystrophy
Kenneth Fischbeck, MD, of the National Institute of Neurological Disorders and Stroke (NINDS) talks about the recent study he and his colleagues performed in boys with Duchenne muscular dystrophy who were receiving exon-skipping therapy to see examine whether non intrusive measures could be used to determine if a treatment is affecting muscle function.
